| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097406A1 Hydantoin derivatives used as mmp inhibitors |
| 09/09/2009 | EP2097405A2 Anti-viral compounds |
| 09/09/2009 | EP2097386A2 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 09/09/2009 | EP2097385A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/09/2009 | EP2097374A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 09/09/2009 | EP1856045B1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 09/09/2009 | CN101525393A Oxime ester photoinitiator and preparation method thereof |
| 09/09/2009 | CN101524356A Use of dopamine D3 receptor ligands for production of drugs for treating renal function disorders |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585885 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/08/2009 | US7585882 Phosphodiesterase 4 inhibitors |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585861 HIV replication inhibitors; for (multi)drug resistant HIV infection |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
| 09/03/2009 | WO2009108798A1 Method for treating pain syndrome and other disorders |
| 09/03/2009 | WO2009108384A2 Compounds and compositions that cause non-apoptotic cell death and uses thereof |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106980A2 Indazole derivatives |
| 09/03/2009 | WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists |
| 09/03/2009 | WO2009106471A2 New angiotensin ii receptor blocker derivatives |
| 09/03/2009 | WO2009106470A2 Angiotensin ii receptor antagonists |
| 09/03/2009 | WO2009106307A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | WO2009105881A1 Ionic liquids comprising ligands containing positively charged heterocyclic ring useful as catalyst and for metal extractions |
| 09/03/2009 | WO2009105825A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | WO2009058937A3 Heteroaryl ethers and processes for their preparation |
| 09/03/2009 | US20090221822 Process for the Preparation of Dihydroquinazolines |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221618 Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors |
| 09/03/2009 | US20090221616 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 09/03/2009 | US20090221606 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-ylimethanone phosphate |
| 09/03/2009 | US20090221605 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221599 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents |
| 09/03/2009 | US20090221587 Novel insecticides |
| 09/03/2009 | US20090221582 Piperazine Derivatives And Their Use In Therapy |
| 09/03/2009 | US20090221574 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 09/03/2009 | US20090221555 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090220992 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2 |
| 09/03/2009 | US20090219526 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy |
| 09/03/2009 | CA2717110A1 Compounds, complexes and uses thereof |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716613A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | CA2716256A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | CA2712695A1 New angiotensin ii receptor blocker derivatives |
| 09/03/2009 | CA2712689A1 Angiotensin ii receptor antagonists |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094682A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 09/02/2009 | EP2094681A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094666A1 Cannabinoid receptor modulators |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1844019B1 Methode for the production of losartan |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | CN101522664A Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| 09/02/2009 | CN101522663A Benzoylpyrazoles, their use as as herbicides, and intermediates |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534990C Pyrrolidone carboxamides |
| 09/01/2009 | US7582773 Thrombosis; antiischemic agents; chronic obstructive pulmonary disease; antidiabetic agents; antiarthritic agents ; Alzheimer's disease; anticancer agents; strokes; cardiovascular disorders |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582761 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582760 Benzimidazolone and dihydroindolone derivatives and uses thereof |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |